PD L1 News and Research

RSS
Novel biomarker-guided approach has potential for treatment of common liver cancer

Novel biomarker-guided approach has potential for treatment of common liver cancer

Non-classical monocytes directly involved in regulation of immune response

Non-classical monocytes directly involved in regulation of immune response

Researchers provide insight into unintended consequence of immune checkpoint inhibitors

Researchers provide insight into unintended consequence of immune checkpoint inhibitors

Researchers develop novel imaging test to predict immunotherapy response in kidney cancer

Researchers develop novel imaging test to predict immunotherapy response in kidney cancer

Combination immunotherapy shows promise in pre-surgical setting for early-stage lung cancers

Combination immunotherapy shows promise in pre-surgical setting for early-stage lung cancers

Immunotherapy increases five-year survival rate of patients with advanced non-small cell lung cancer

Immunotherapy increases five-year survival rate of patients with advanced non-small cell lung cancer

Pre-surgical neoadjuvant treatment shows promise in trial for patients with operable NSCLC

Pre-surgical neoadjuvant treatment shows promise in trial for patients with operable NSCLC

FDA approves new treatment for adults with metastatic bladder cancer

FDA approves new treatment for adults with metastatic bladder cancer

Unusually small antibodies could help CAR T-cell therapies to kill solid tumors

Unusually small antibodies could help CAR T-cell therapies to kill solid tumors

Low-dose radiation therapy may increase uptake of therapeutic nanoparticles by brain tumors

Low-dose radiation therapy may increase uptake of therapeutic nanoparticles by brain tumors

Radiolabeled protein lights up tumor to reveal where cancer drugs are working

Radiolabeled protein lights up tumor to reveal where cancer drugs are working

City of Hope exhibits current studies and data on cancer therapies at AACR

City of Hope exhibits current studies and data on cancer therapies at AACR

City of Hope receives $7.5 million in grant awards to study cutaneous T cell lymphoma

City of Hope receives $7.5 million in grant awards to study cutaneous T cell lymphoma

Preclinical data shows combination immunotherapy could suppress tumor growth in the liver

Preclinical data shows combination immunotherapy could suppress tumor growth in the liver

First molecular test predicts treatment response for kidney cancer

First molecular test predicts treatment response for kidney cancer

Combination of PARP inhibitor and immunotherapy results in tumor regression in SCLC mouse models

Combination of PARP inhibitor and immunotherapy results in tumor regression in SCLC mouse models

Drug combinations could become first-line treatment for metastatic kidney cancer

Drug combinations could become first-line treatment for metastatic kidney cancer

Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors

Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors

Novel approach uses small amounts of tissue to quantify PD-L1 expression levels in tumors

Novel approach uses small amounts of tissue to quantify PD-L1 expression levels in tumors

Immunotherapy may be better than chemotherapy for Merkel cell carcinoma

Immunotherapy may be better than chemotherapy for Merkel cell carcinoma